Medical Advocates
HIV Infection/Disease
  Anemia

 General Reports 
 Pregnancy
 Clinical Management 
Drugs 
 National Studies






 
Symptom Management New/Newsworthy Home Page
Last Update:  October 04, 2008
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General Reports
 

        Journal Papers, Abstracts, and Commentaries

 
Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens
in 9690 human immunodeficiency virus-infected patients: findings of the Anemia Prevalence
Study.
Mildvan D, Creagh T, Leitz G; The Anemia Prevalence Study
Curr Med Res Opin. 2007 Feb;23(2):343-55.
 Abstract
 
The impact of anemia on energy and physical functioning in individuals with AIDS.
 Semba RD, Martin BK, Kempen JH, et al
Arch Intern Med. 2005 Oct 24;165(19):2229-36.
 Abstract
 
Haemopoiesis defects in HIV/AIDS-anaemia
Snopkova S, Matyskova M, Husa P, Svoboda R.
Klin Mikrobiol Infekc Lek. 2005 Sep;11(4):123-127.
Abstract
 
Anemia in HIV-Infected Adults: Epidemiology, Pathogenesis, and Clinical Management.
 Fangman JJ, Scadden DT.
Curr Hematol Rep. 2005 Mar;4(2):95-102.
Abstract
 
Prevalence and outcomes of anemia in individuals with human immunodeficiency
virus: a systematic review of the literature.
 Belperio PS, Rhew DC.
 Am J Med. 2004 Apr 5;116 Suppl 7A:27-43.
 Abstract
 
Implications of anemia in human immunodeficiency virus, cancer, and hepatitis C virus.
Mildvan D
Clin Infect Dis. 2003;37 Suppl 4:S293-6.
 Abstract

Anaemia in persons with HIV infection: prognostic marker and contributor to
morbidity.
 Moyle G.
 AIDS Rev 2002 Jan-Mar;4(1):13-20
 Abstract

Associations of anemia, treatments for anemia, and survival in patients with
human immunodeficiency virus infection.
Sullivan P.
J Infect Dis. 2002 May 15;185 Suppl 2:S138-42.
 Abstract
 
The impact of anemia on quality of life in human immunodeficiency virus-infected
patients.
Volberding P.
J Infect Dis. 2002 May 15;185 Suppl 2:S110-4.
 Abstract
 

     Conference Reports, Abstracts, and Posters

 
Predictors of anemia type and relationship to mortality
Fultz S.L., McGinnis K.A., Berliner N., et al
 (XVI International AIDS Conference)
 Abstract

Direct and indirect costs of untreated anemia in patients with HIV
Moyneur É., Bookhart B.K., Zilberberg M
 (XVI International AIDS Conference)
 Abstract
Clinical Management
 

        Journal Papers, Abstracts, and Commentaries

 
Treatment for anemia in people with AIDS.
 Marti-Carvajal Aj Sola I.
 Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004776.
 Abstract
 
Anemia in HIV Infection: Clinical Impact and Evidence-Based Management Strategies.
 Volberding PA, Levine AM, Dieterich D, et al.
Clin Infect Dis. 2004 May 15;38(10):1454-63.
 Abstract
 
Anemia and its treatment and outcomes in persons infected with human immunodeficiency
virus.
Buskin SE, Sullivan PS. 
Transfusion. 2004 Jun;44(6):826-832
 Abstract

Management of anemia of chronic disease in patients with the human immunodeficiency
virus.
 Brokering KL, Qaqish RB.
Pharmacotherapy. 2003 Nov;23(11):1475-85.
Abstract

Treatment of anemia in patients with HIV Infection--Part 2: guidelines for management
of anemia.
Ferri RS, Adinolfi A, Orsi AJ, et al
J Assoc Nurses AIDS Care. 2002 Jan-Feb;13(1):50-9
 Abstract
Drugs
                  
HAART

        Journal Papers, Abstracts, and Commentaries

 
Impact of Highly Active Antiretroviral Therapy on Anemia and Relationship Between
Anemia and Survival in a Large Cohort of HIV-Infected Women: Women's Interagency
HIV Study.
Berhane K, Karim R, Cohen MH, et al
J Acquir Immune Defic Syndr. 2004 Oct 1;37(2):1245-1252.
Abstract

Highly active antiretroviral therapy associated with improved anemia among hiv-infected
women.
Semba RD, Shah N, Klein RS, et al.
AIDS Patient Care STDS 2001 Sep;15(9):473-80
 Abstract
 
Erythropoietin
 
     Internet Document
 
  FULL-TEXT DOCUMENT
FDA Warning: Erythropoiesis Stimulating Agents:Aranesp (darbepoetin alfa),
Epogen (epoetin alfa), Procrit (epoetin alfa)
 US FDA
March 09, 2007
 Internet Document

       Journal Papers, Abstracts, and Commentaries

 
Epoetin Alfa for Treatment of Anemia in HIV-Infected Patients: Past, Present, and
Future.
Henry DH, Volberding PA, Leitz G.. et al
J Acquir Immune Defic Syndr. 2004 Oct 1;37(2):1221-1227.
 Abstract
 
Erythropoietin protects cerebrocortical neurons from HIV-1/gp120-induced damage.
 Digicaylioglu M, Kaul M, Fletcher L, et al
 Neuroreport. 2004 Apr 9;15(5):761-3.
Abstract
 
Once-Weekly Epoetin Alfa Dosing Is as Effective as Three Times-Weekly Dosing in
Increasing Hemoglobin Levels and Is Associated With Improved Quality of Life in Anemic
HIV-Infected Patients.
 Grossman HA, Goon B, Bowers P, et al 
J Acquir Immune Defic Syndr. 2003 Dec 1;34(4):368-78
 Abstract
 
Breastmilk erythropoietin and mother-to-child HIV transmission through breastmilk.
Miller M, Iliff P, Stoltzfus RJ, Humphrey J.
Lancet. 2002 Oct 19;360(9341):1246-8.
 Abstract
 
Maximizing response to erythropoietin in treating HIV-associated anemia.
Ifudu O.
Cleve Clin J Med. 2001 Jul;68(7):643-8.
 Abstract
 
Epoetin alfa therapy for anaemia in HIV-infected patients: impact on quality of life.
Abrams DI, Steinhart C, Frascino R.
Int J STD AIDS. 2000 Oct;11(10):659-65
 Abstract
 

Testosterone

        Journal Papers, Abstracts, and Commentaries

  Anemia and HIV in the Antiretroviral Era: Potential Significance of Testosterone.
 Behler C, Shade S, Gregory K, et al 
AIDS Res Hum Retroviruses. 2005 Mar;21(3):200-6.
Abstract

Symptom Management New/Newsworthy Home Page

HIV Infection/Disease/Anemia